Common Contracts
3 similar Underwriting Agreement contracts by Motif Bio PLC
EX-4.15 2 a17-11992_1ex4d15.htm EX-4.15 2,438,491 AMERICAN DEPOSITARY SHARES, EACH REPRESENTING 20 ORDINARY SHARES, £0.01 PAR VALUE, AND WARRANTS TO PURCHASE 1,219,246 AMERICAN DEPOSITARY SHARES MOTIF BIO PLC UNDERWRITING AGREEMENT November 17, 2016...Underwriting Agreement • May 5th, 2020 • New York
Motif Bio plc, a public limited company incorporated in England and Wales (the “Company”), hereby agrees, subject to the terms and conditions stated in this Underwriting Agreement (the “Agreement”), to issue and sell to the several Underwriters named in Schedule I hereto (collectively, the “Underwriters” and, each, an “Underwriter”) for which H.C. Wainwright & Co., LLC is acting as representative to the several Underwriters (the “Representative” or “you” and, if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter), an aggregate of (i) 2,438,491 American Depositary Shares of the Company (the “ADSs”), each ADS representing 20 of the Company’s ordinary shares, par value £0.01 per share (the “Ordinary Shares”), and (ii) 1,219,246 warrants to purchase ADSs (the “ADS Warrants”), in substantially the form filed as an exhibit to the Registration St
2,438,491 AMERICAN DEPOSITARY SHARES, EACH REPRESENTING 20 ORDINARY SHARES, £0.01 PAR VALUE, AND WARRANTS TO PURCHASE 1,219,246 AMERICAN DEPOSITARY SHARES MOTIF BIO PLC UNDERWRITING AGREEMENTUnderwriting Agreement • May 1st, 2017 • Motif Bio PLC • Pharmaceutical preparations • New York
This letter is delivered to you pursuant to the Underwriting Agreement (the “Underwriting Agreement”) to be entered into by the Company, as issuer, and Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC, as representative (the “Representative”) of certain underwriters (the “Underwriters”) to be named therein. Upon the terms and subject to the conditions of the Underwriting Agreement, the Underwriters intend to effect a public offering of American Depositary Shares (“ADSs”), each of which represents 20 Ordinary Shares, of one penny each in capital, of the Company (the “Ordinary Shares”), and warrants (“Warrants”) to purchase ADSs, as described in and contemplated by the registration statement of the Company on Form F-1, File No. 333-212491 (the “Registration Statement”), as subsequently amended (the “Offering”).
AMERICAN DEPOSITARY SHARES, EACH REPRESENTING 20 ORDINARY SHARES, £0.01 PAR VALUE, AND WARRANTS TO PURCHASE AMERICAN DEPOSITARY SHARES MOTIF BIO PLC UNDERWRITING AGREEMENTUnderwriting Agreement • November 4th, 2016 • Motif Bio PLC • Pharmaceutical preparations • New York
